Loading...
Loading...
Analysts at Jefferies downgraded Ampio Pharmaceuticals
AMPE from Buy to Hold.
The target price for Ampio Pharmaceuticals has been lowered from $14 to $5.
Ampio Pharmaceuticals shares have fallen 15.02% over the past 52 weeks, while the S&P 500 index has surged 19.77% in the same period.
Ampio Pharmaceuticals' shares rose 0.71% to $5.70 in pre-market trading.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in